Erstellt von conna
Amgen Inc. diskutieren
Amgen Inc.
WKN: 867900 / Symbol: AMGN / Name: Amgen / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
289,20 €
10,96 %
Übersetzung fehlgeschlagen
Die Übersetzung durch Google Translate ist leider fehlgeschlagen.
(Vom Mitglied beendet)
Sell Amgen Inc.
Buy Amgen Inc.
Sell Amgen Inc.
Sell Amgen Inc.
Sell Amgen Inc.
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $265.00 price target on the stock, down previously from $275.00.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $292.00 to $290.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $280.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Argus from $260.00 to $280.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Oppenheimer Holdings Inc. from $280.00 to $290.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at SVB Leerink LLC from a "market perform" rating to an "outperform" rating.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $310.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at Leerink Partnrs from a "market perform" rating to an "outperform" rating.
Ratings data for AMGN provided by MarketBeat
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Argus from $280.00 to $310.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
Neueste Beiträge
Benchmark_Co_ in Select Medical Holdings diskutieren